{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:32:06Z","timestamp":1770831126974,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The impact of the COVID-19 pandemic on the mental health of patients suffering from addictive disorders is of major concern. This study aimed to explore the presence and potential increase in post-traumatic stress disorder (PTSD) symptoms, depression, and anxiety since the beginning of the pandemic for patients in opioid substitution therapy (OST).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This cross-sectional survey study evaluated a clinical sample of patients in OST (<jats:italic>N<\/jats:italic> = 123). Symptoms of post-traumatic stress disorder (PTSD) due to the COVID-19 pandemic were assessed by an adapted version of the impact of event scale (IES-R), resulting in two subgroups of low and high risk for PTSD. The depression, anxiety, and stress scale (DASS-21) was applied to collect data on the respective symptoms, and changes since the onset of the pandemic were reported on separate scales. Sociodemographic and COVID-19 related factors, as well as data on craving, consumption patterns, concomitant use, and the drug market were further assessed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A binary logistic regression analysis confirmed the impact of self-perceived higher burden by psychological and economic factors on the elevated risk for PTSD due to the pandemic. The high-risk PTSD group also showed higher levels of depression, anxiety and stress, as well as a more pronounced deterioration in these symptoms since the pandemic. While reported levels of craving did not differ between the two groups, the high-risk PTSD group indicated a significantly higher increase in craving since the crisis, when compared to the low-risk group.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Our findings demonstrate elevated levels of clinical symptoms among patients in OST, with more than a quarter of patients found at risk for PTSD due to the COVID-19 pandemic. Furthermore, about 30\u201350% of our patients reported concerning levels of depression, anxiety, or stress. Special attention should be drawn to these findings, and potential deterioration of the situation should be addressed by health care facilities. Particularly, psychological, and financial burden due to the crisis were identified as factors increasing the risk for PTSD. These factors can easily be evaluated during routine anamneses, and might be a valuable source of information, when special attention is needed.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.729460","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T06:13:32Z","timestamp":1632982412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of PTSD Due to the COVID-19 Pandemic Among Patients in Opioid Substitution Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Isabella","family":"Fuchs-Leitner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurosch","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas W.","family":"Gerstgrasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias G.","family":"Tholen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie-Ther\u00e9s","family":"Graffius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schorb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rosenleitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0020764020915212","article-title":"The outbreak of COVID-19 coronavirus and its impact on global mental health","volume":"66","author":"Torales","year":"2020","journal-title":"Int J Soc Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamainternmed.2020.1562","article-title":"The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention","volume":"180","author":"Galea","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","article-title":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence","volume":"395","author":"Brooks","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jad.2020.09.047","article-title":"Depression in and after COVID-19 lockdown in Austria and the role of stress and loneliness in lockdown: a longitudinal study","volume":"277","author":"Probst","year":"2020","journal-title":"J Affect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/ajad.13066","article-title":"Brief report: increased addictive internet and substance use behavior during the COVID-19 pandemic in China","volume":"29","author":"Sun","year":"2020","journal-title":"Am J Addict."},{"key":"B6","doi-asserted-by":"publisher","first-page":"620612","DOI":"10.3389\/fpsyt.2020.620612","article-title":"Impact of the COVID-19 pandemic on patients with alcohol use disorder and associated risk factors for relapse","volume":"11","author":"Yazdi","year":"2020","journal-title":"Front Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"602033","DOI":"10.3389\/fpsyt.2020.602033","article-title":"Developments in drug addiction during COVID-19\u2014an Austrian perspective based on a clinical sample","volume":"11","author":"Fuchs-Leitner","year":"2020","journal-title":"Front Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"102064","DOI":"10.1016\/j.ajp.2020.102064","article-title":"COVID-19 pandemic and addiction: current problems and future concerns","volume":"51","author":"Kar","year":"2020","journal-title":"Asian J Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fpsyt.2020.00714","article-title":"Substance use disorders and COVID-19: multi-faceted problems which require multi-pronged solutions","volume":"11","author":"Jemberie","year":"2020","journal-title":"Front Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/add.15080","article-title":"Mitigating and learning from the impact of COVID-19 infection on addictive disorders","volume":"115","author":"Marsden","year":"2020","journal-title":"Addiction."},{"key":"B12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2021.05.006","article-title":"Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: risk factors for adverse mental health outcomes","volume":"139","author":"Blithikioti","year":"2021","journal-title":"J Psychiatr Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"572245","DOI":"10.3389\/fpsyt.2020.572245","article-title":"Psychopathological burden and quality of life in substance users during the COVID-19 lockdown period in Italy","volume":"11","author":"Martinotti","year":"2020","journal-title":"Front Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/wps.20764","article-title":"The relevance of COVID-19 pandemic to psychiatry","volume":"19","author":"Marazziti","year":"2020","journal-title":"World Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"567367","DOI":"10.3389\/fpsyg.2020.567367","article-title":"Individual differences, economic stability, and fear of contagion as risk factors for PTSD symptoms in the COVID-19 emergency","volume":"11","author":"Di Crosta","year":"2020","journal-title":"Front Psychol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fpsyt.2020.00738","article-title":"Validation of the Impact of Event Scale With Modifications for COVID-19 (IES-COVID19)","volume":"11","author":"Vanaken","year":"2020","journal-title":"Front Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000365283","article-title":"Screening of current post-traumatic stress disorder in patients with substance use disorder using the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure","volume":"21","author":"Kok","year":"2015","journal-title":"Eur Addict Res."},{"key":"B18","year":"2013"},{"key":"B19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.addbeh.2009.01.002","article-title":"Gender and comorbidity among individuals with opioid use disorders in the NESARC study","volume":"34","author":"Grella","year":"2009","journal-title":"Addict Behav."},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/15504263.2020.1726549","article-title":"Depression and outcomes of methadone and buprenorphine treatment among people with opioid use disorders: a literature review","volume":"16","author":"Ghabrash","year":"2020","journal-title":"J Dual Diagn."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00213-018-4966-9","article-title":"Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder","volume":"235","author":"Preston","year":"2018","journal-title":"Psychopharmacology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2019.05.026","article-title":"Stress, craving and mood as predictors of early dropout from opioid agonist therapy","volume":"202","author":"Panlilio","year":"2019","journal-title":"Drug Alcoh Depend."},{"key":"B23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbi.2020.05.040","article-title":"Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain","volume":"87","author":"Gonz\u00e1lez-Sanguino","year":"2020","journal-title":"Brain Behavior Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/ijerph17051729","article-title":"Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China","volume":"17","author":"Wang","year":"2020","journal-title":"IJERPH."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1017\/S0033291720001336","article-title":"PTSD as the second tsunami of the SARS-Cov-2 pandemic","volume":"51","author":"Dutheil","year":"2020","journal-title":"Psychol Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"112921","DOI":"10.1016\/j.psychres.2020.112921","article-title":"Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter","volume":"287","author":"Liu","year":"2020","journal-title":"Psychiatry Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/ijerph17093165","article-title":"A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors","volume":"17","author":"Mazza","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-020-00370-7","article-title":"Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic","volume":"17","author":"Dunlop","year":"2020","journal-title":"Harm Reduct J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000438988","article-title":"The impact of misuse and diversion of opioid substitution treatment medicines: evidence review and expert consensus","volume":"22","author":"Reimer","year":"2016","journal-title":"Eur Addict Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1747-597X-9-46","article-title":"Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study","volume":"9","author":"Baumeister","year":"2014","journal-title":"Subst Abuse Treat Prev Policy."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","article-title":"A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence","volume":"102","author":"Bell","year":"2007","journal-title":"Addiction."},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jsat.2014.08.006","article-title":"Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance","volume":"48","author":"Jaremko","year":"2015","journal-title":"J Subst Abuse Treat."},{"key":"B33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/dar.13079","article-title":"Illicit drug use and harms in Australia in the context of COVID-19 and associated restrictions: anticipated consequences and initial responses","volume":"39","author":"Dietze","year":"2020","journal-title":"Drug Alcoh Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"102156","DOI":"10.1016\/j.ajp.2020.102156","article-title":"Addressing psychosocial problems associated with the COVID-19 lockdown","volume":"51","author":"Mackolil","year":"2020","journal-title":"Asian J Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41591-020-0887-3","article-title":"An overdose surge will compound the COVID-19 pandemic if urgent action is not taken","volume":"26","author":"Wakeman","year":"2020","journal-title":"Nat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and addiction epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann Intern Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid use disorder and COVID-19: crashing of the crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J Addict Med"},{"key":"B38","first-page":"321","article-title":"The impact of event scale\u2013revised (IES-R)","volume":"21","author":"Christianson","year":"2012","journal-title":"Medsurg Nursing."},{"key":"B39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.15288\/jsad.2014.75.313","article-title":"Internet-based screening and brief intervention for illicit drug users: a randomized controlled trial with 12-month follow-up","volume":"75","author":"Sinadinovic","year":"2014","journal-title":"J Stud Alcoh Drugs."},{"key":"B40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"Eur Addict Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/jcm10051008","article-title":"The psychological impact of the COVID-19 pandemic on dentists in Germany","volume":"10","author":"Mekhemar","year":"2021","journal-title":"JCM."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.addbeh.2008.04.006","article-title":"Psychometric properties of the IES-R in traumatized substance dependent individuals with and without PTSD","volume":"33","author":"Rash","year":"2008","journal-title":"Addict Behav."},{"key":"B43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00482-015-0019-z","article-title":"Die Depressions-Angst-Stress-Skalen: Der DASS \u2013 ein Screeningverfahren nicht nur f\u00fcr Schmerzpatienten","volume":"29","author":"Nilges","year":"2015","journal-title":"Schmerz."},{"key":"B44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample","volume":"44","author":"Henry","year":"2005","journal-title":"Br J Clin Psychol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ijop.12671","article-title":"Psychometric properties and measurement invariance of Depression, Anxiety and Stress Scales (DASS-21) across cultures","volume":"55","author":"Bibi","year":"2020","journal-title":"Int J Psychol."},{"key":"B46","volume-title":"IBM SPSS Statistics for Windows, Version 25.0","author":"IBM","year":"2017"},{"key":"B47","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"B48","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"B49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000485182","article-title":"The Depression, Anxiety and Stress Scale (DASS-21) as a screener for depression in substance use disorder inpatients: a pilot study","volume":"23","author":"Beaufort","year":"2017","journal-title":"Eur Addict Res."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.729460\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T06:13:37Z","timestamp":1632982417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.729460\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":49,"alternative-id":["10.3389\/fpsyt.2021.729460"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.729460","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"729460"}}